These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16914868)

  • 21. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
    Liu G; Men P; Harris PL; Rolston RK; Perry G; Smith MA
    Neurosci Lett; 2006 Oct; 406(3):189-93. PubMed ID: 16919875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferric cycle activity and Alzheimer disease.
    Dwyer BE; Takeda A; Zhu X; Perry G; Smith MA
    Curr Neurovasc Res; 2005 Jul; 2(3):261-7. PubMed ID: 16181119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron: a pathological mediator of Alzheimer disease?
    Bishop GM; Robinson SR; Liu Q; Perry G; Atwood CS; Smith MA
    Dev Neurosci; 2002; 24(2-3):184-7. PubMed ID: 12401957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of metals in neurodegenerative diseases.
    Sayre LM; Perry G; Atwood CS; Smith MA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):731-41. PubMed ID: 10875436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
    Cornett CR; Markesbery WR; Ehmann WD
    Neurotoxicology; 1998 Jun; 19(3):339-45. PubMed ID: 9621340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target.
    Faller P; Hureau C
    Chemistry; 2012 Dec; 18(50):15910-20. PubMed ID: 23180511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
    Moneim AE
    Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular oxidative stress in Alzheimer disease.
    Zhu X; Smith MA; Honda K; Aliev G; Moreira PI; Nunomura A; Casadesus G; Harris PL; Siedlak SL; Perry G
    J Neurol Sci; 2007 Jun; 257(1-2):240-6. PubMed ID: 17337008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal localization of iron regulatory protein in Alzheimer's disease.
    Smith MA; Wehr K; Harris PL; Siedlak SL; Connor JR; Perry G
    Brain Res; 1998 Mar; 788(1-2):232-6. PubMed ID: 9555030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration.
    Gutteridge JM
    Ann N Y Acad Sci; 1994 Nov; 738():201-13. PubMed ID: 7832429
    [No Abstract]   [Full Text] [Related]  

  • 34. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease.
    Becaria A; Bondy SC; Campbell A
    J Alzheimers Dis; 2003 Feb; 5(1):31-8. PubMed ID: 12590164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the possible role of iron-induced free radical peroxidation in neural degeneration in Alzheimer's disease.
    Richardson JS; Subbarao KV; Ang LC
    Ann N Y Acad Sci; 1992 May; 648():326-7. PubMed ID: 1322084
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain iron deposition and the free radical-mitochondrial theory of ageing.
    Schipper HM
    Ageing Res Rev; 2004 Jul; 3(3):265-301. PubMed ID: 15231237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential in Alzheimer disease.
    Cash AD; Perry G; Smith MA
    Curr Med Chem; 2002 Sep; 9(17):1605-10. PubMed ID: 12171555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.